Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Johnson & Johnson Stock Flopped Today


Johnson & Johnson (NYSE: JNJ) stock had a bit of a hangover Wednesday. Following the estimates-beating third-quarter results that the company posted Tuesday, its share price fell by more than 2%. That tumble exceeded the 1.3% decline of the benchmark S&P 500 index.

Before the market open Wednesday, a pair of pundits tracking Johnson & Johnson stock lowered their fair value estimations of the healthcare giant. 

Terrance Flynn from white-shoe investment bank Morgan Stanley lowered his by $3 to a new price target of $171 per share. Jayson Bedford of Raymond James made a slightly deeper cut, reducing his target to $172 from the preceding level of $179. 

Continue reading


Source Fool.com

Like: 0
JNJ
Share

Comments